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Downing: A Blatant Inequity

LAW SUMMARY
A Blatant Inequity: Contributions to the
Common Benefit Fund in Multidistrict
Litigation
Jack Downing*

I. INTRODUCTION
The U.S. legal system is a remarkable mechanism that strives to operate
with justice and efficiency. However, it is not without flaws and loopholes.
Upon discovery, these defects are often exploited for the material benefit of
those involved.1 In a profession where every hour is counted, practicing attorneys often attempt to earn as much money as possible while expending the
least amount of time.2 Somewhere along the line, many attorneys lose sight
of what really matters – serving their clients and the justice system.
This Note discusses a growing problem in cases with an established
common benefit fund (“CBF”) for attorneys’ fees, where a judge orders all
parties involved to set aside a percentage of the recovery to ensure that each
attorney is adequately compensated for his or her services. Specifically, in
federal multidistrict mass tort litigation, plaintiffs’ attorneys often have clients in both federal and state court who have been harmed by the same party
and through the same conduct.3 In these circumstances, if a CBF is established in federal court, all attorneys involved will have access to the work
product conducted in furtherance of the federal litigation.4 There is nothing
stopping those attorneys from applying the common work product to their

*
B.A., University of Missouri, 2014; J.D. Candidate, University of Missouri School
of Law, 2017; Note and Comment Editor, Missouri Law Review, 2016–2017. This
Note is written with much appreciation for Professor R. Lawrence Dessem for guidance and the Missouri Law Review for editorial assistance. Also, I would like to express my gratitude to the law firm of Gray, Ritter & Graham, P.C. I was inspired to
write this Note after spending a summer with the firm.
1. See Deborah R. Hensler, Revisiting the Monster: New Myths and Realities of
Class Action and Other Large Scale Litigation, 11 DUKE J. COMP. & INT’L L. 179,
180 (2001).
2. Joseph E. La Rue, Note, Redeeming the Lawyer’s Time: A Proposal for a
Shift in How Attorneys Think About – and Utilize – Time, 20 NOTRE DAME J.L.
ETHICS & PUB. POL’Y 473, 499 (2006).
3. See Byron G. Stier, Resolving the Class Action Crisis: Mass Tort Litigation
as Network, 2005 UTAH L. REV. 863, 915–16.
4. In re Syngenta AG MIR 162 Corn Litig., MDL No. 2591, 2015 WL
2165341, at *2 (D. Kan. May 8, 2015).
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current and future cases filed in state court.5 Accordingly, if plaintiffs’ attorneys are successful in their state court litigation, they will not have to contribute any portion of their state court recovery to the federal court CBF.6 As
a result, attorneys can effectively obtain the benefit of work product created
by other attorneys without paying for it. Federal multidistrict litigation
(“MDL”) often involves hundreds of depositions, dozens of experts, and millions of documents for review.7 The cost of this work product can amount to
millions of dollars and tens of thousands of hours of time.8 This inherent
unfairness should not exist in our justice system.
This Note analyzes the nuances of this issue and offers resolutions to its
fundamental problems. Part II includes an overview of the MDL litigation,
the plaintiffs’ lead counsel selection process, and the function and nature of
CBFs. This Part will also include the judicial justification for creating a CBF
in federal MDLs. Part III examines current problems with CBFs. In particular, this Part will focus on plaintiffs’ attorneys’ ability to use work product
obtained for the federal MDL in their concurrent state court cases without
having to contribute any portion of their recovery in state court to the federal
CBF. Part IV will then examine the arguments for and against ordering
plaintiffs’ attorneys to contribute a portion of their state court recoveries to
the federal CBF.

II. LEGAL BACKGROUND
In order to conserve judicial resources, the Judicial Panel on Multidistrict Litigation (“JPML”) assigns a single district court, one with personal
jurisdiction and proper venue, to an MDL pursuant to 28 U.S.C. § 1407.9
This allows all relevant federal cases to be consolidated into a single proceeding.10 For purposes of efficiency, similar cases in state court may be removed
to the federal district court if diversity exists and the removal requirements
are satisfied.11 After the JPML assigns the case to the proper district court,
the judge in that district will appoint a leadership counsel on behalf of all the
plaintiffs in the MDL.12 In making his or her decision, the judge considers a
variety of different factors, including “the attorneys’ ability to command the
respect of their colleagues and work cooperatively” with everyone involved
5. Id. at *7–8.
6. Id. at *4.
7. See Danielle Oakley, Note, Is Multidistrict Litigation a Just and Efficient

Consolidation Technique? Using Diet Drug Litigation as a Model to Answer This
Question, 6 NEV. L.J. 494, 497–98 (2006).
8. See Tanya Pierce, It’s Not Over ‘Til It’s Over: Mandating Federal Pretrial
Jurisdiction and Oversight in Mass Torts, 79 MO. L. REV. 27, 36 (2014).
9. FED. JUDICIAL CTR., MANUAL FOR COMPLEX LITIGATION 11 (Stanley Marcus
et al. eds., 4th ed. 2004), https://public.resource.org/scribd/8763868.pdf.
10. Id.
11. Id.; see also 28 U.S.C.A. §§ 1441–1452 (West 2016).
12. See FED. JUDICIAL CTR., supra note 9, at 26–27.
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in the MDL.13 Courts believe this is especially important, because the leadership counsel determines the plaintiffs’ strategic course of action and establishes a CBF to which all of the plaintiffs’ attorneys involved must contribute.14
The prevalence of MDL lawsuits has increased over the past several
decades.15 In 2014, 120,449 MDL actions were pending in federal courts,
affecting hundreds of thousands of attorneys and plaintiffs across the country.16 In total, MDLs make up nearly forty percent of all federal civil actions.17
The common benefit governing principles are derived from the common
benefit doctrine, which was initially established in Trustees v. Greenough.18
The Manual for Complex Litigation outlines the doctrine.19 It states:
Lead and liaison counsel may have been appointed by the court to perform functions necessary for the management of the case but not appropriately charged to their clients. Early in the litigation, the court
should . . . determine the method of compensation . . . and establish
the arrangements for their compensation, including setting up a fund
to which designated parties should contribute in specified proportions.
Guidelines should cover staffing, hourly rates, and estimated charges
for services and expenses.20

13. Id.
14. See In re Diet Drugs (Phentermine, Fenfluramine, Dexfenfluramine) Prods.

Liab. Litig., MDL No. 1203, 2002 WL 32154197, at *6–8 (E.D. Pa. Oct. 3, 2002)
modified by MDL No. 1203, 2003 WL 22218322 (E.D. Pa. May 15, 2003).
15. U.S. JUDICIAL PANEL ON MULTIDISTRICT LITIG., STATISTICAL ANALYSIS OF
MULTIDISTRICT LITIGATION FISCAL YEAR 2014: CUMULATIVE FROM SEPTEMBER 1968
THROUGH
SEPTEMBER
30,
2014,
3
(2014),
http://www.jpml.uscourts.gov/sites/jpml/files/JPML_Statistical%20Analysis%20of%
20Multidistrict%20Litigation_2014.pdf.
16. Amaris Elliott-Engel, Study: MDLs See Bigger Chunk of Federal Dockets,
NAT’L
LAW
J.
(Oct.
29,
2014),
http://www.nationallawjournal.com/id=1202675010547/Study-MDLs-See-BiggerChunk-of-Federal-Dockets.
17. Id.
18. Internal Imp. Fund Trs. v. Greenough, 105 U.S. 527, 532–33 (1881) (“It is a
general principle that a trust estate must bear the expenses of its administration. It is
also established by sufficient authority, that where one of many parties having a
common interest in a trust fund, at his own expense takes proper proceedings to save
it from destruction and to restore it to the purposes of the trust, he is entitled to reimbursement, either out of the fund itself, or by proportional contribution from those
who accept the benefit of his efforts.”).
19. See FED. JUDICIAL CTR., supra note 9, at 202.
20. Id.
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For decades, CBFs have been used as a means to justly compensate attorneys for their services in MDLs.21 Traditionally, in a single action, an
attorney receives a fixed percentage of the recovery, as a contingency fee, if
there is a settlement or if the plaintiff is awarded damages.22 In an MDL,
attorneys, including those in the leadership group, often perform “duties beyond their responsibilities to their own clients.”23 These duties include taking
depositions, hiring experts, and reviewing documents to an extent well beyond what would be required in an individual case.24 Attorneys assume these
duties to benefit all plaintiffs as a whole, and the work product obtained by
the leadership counsel is accessible to all plaintiffs’ attorneys involved in the
litigation.25 Since every attorney receives the benefit of the work product
obtained by only a few, creating a CBF is “a necessary incident to achievement of the goals of multidistrict litigation.”26 In order to prevent this inequity, it is necessary to implement a proportional payment system based on the
amount of work performed by each attorney.27 The costs of which will be
distributed among those who benefit from the common work product.28
To establish a CBF, the plaintiffs’ attorneys involved must meet before
the litigation begins to determine a fair amount to be allocated as a fixed percentage of the recovery.29 The court effectuates the CBF by requiring the
defendant to “hold back” the amount of the CBF from the total recovery.30
The defendant must then pay a percentage to the CBF, pursuant to the court’s
determination made at the outset of the litigation.31 Therefore, upon recovery, the only party over which the court exercises jurisdiction in dealing with
21. In re Air Crash Disaster at Fla. Everglades on Dec. 29, 1972, 549 F.2d 1006,
1011 (5th Cir. 1977).
22. Legal Fees and Expenses: What are Contingent Fees?, AM. BAR ASS’N,
http://www.americanbar.org/groups/public_education/resources/law_issues_for_cons
umers/lawyerfees_contingent.html (last visited June 26, 2016).
23. Air Crash Disaster, 549 F.2d at 1011.
24. Id.
25. See generally In re Genetically Modified Rice Litig., No. 4:06 MD 1811
CDP, 2010 WL 716190 (E.D. Mo. Feb. 24, 2010), aff’d, 764 F.3d 864 (8th Cir. 2014).
26. Air Crash Disaster, 549 F.2d at 1011.
27. Boeing Co. v. Van Gemert, 444 U.S. 472, 478 (1980).
28. Id.
29. Genetically Modified Rice, 2010 WL 716190, at *6 (“Courts have ordered
contributions between 9% and 17% in MDLs for common benefit work.”). These
percentages come from pretrial contract negotiations between the plaintiffs in the
action. Charles Silver, The Responsibilities of Lead Lawyers and Judges in Multidistrict Litigations, 79 FORDHAM L. REV. 1985, 1986 (2011); see also Elizabeth Chamblee Burch, Judging Multidistrict Litigation, 90 N.Y.U. L. REV. 71, 101–02 (2015).
30. Turner v. Murphy Oil USA, Inc., 422 F. Supp. 2d 676, 680 (E.D. La. 2006)
(“[I]t has been a common practice in the federal courts to impose set-asides in the
early stages of complex litigation in order to preserve common-benefit funds for later
distribution.”).
31. Id.; see also In re Zyprexa Prods. Liab. Litig., 467 F. Supp. 2d 256, 267
(E.D.N.Y. 2006).
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the CBF is the defendant; the court does not “levy” the assessment directly on
the plaintiff, but rather orders the defendant to “set aside” a determined percentage as the CBF.32 During the litigation, each attorney logs the number of
hours spent and the type of work conducted.33 Once the recovery is made,
each attorney performing common benefit work is paid from the CBF based
on the number of hours logged, quality of work, overall size of the recovery,
and other factors.34
This system has several loopholes that allow attorneys to avoid fully
contributing to the CBF – a full contribution being one based on the recovery
of every client for whom the MDL work product is applied. As will be discussed below, attorneys will strategically choose to file as many cases as they
can in state court. This prevents them from having to contribute to the CBF
in the MDL for their recovery in state court. As long as these attorneys have
at least one client in the MDL, they will have access to the work product obtained by the leadership group and any other attorney working on the litigation.35 Several courts have addressed this issue.36

III. RECENT DEVELOPMENTS
With the presence of a federal MDL, there are often state court cases involving the same core dispute.37 This can happen when there is a local defendant destroying federal diversity jurisdiction.38 If a plaintiff’s attorney
believes the laws to be more favorable in a certain state, he or she may join a
defendant in that state to defeat diversity and keep the case in that state.39
With no legitimate grounds for joinder other than defeating diversity jurisdiction, a court may rule that the joinder is fraudulent, in which case the judge
will remove the case to the federal MDL.40 For those cases that do not get
removed, the question remains: Does the MDL court have jurisdiction to re32. See Zyprexa Prods., 467 F. Supp. 2d at 266–68; Genetically Modified Rice,
2010 WL 716190, at *1 (“The proposed [CBF] would be funded by defendants’ setting aside a percentage of awards or settlements in all cases related to the MDL.”).
33. See In re Genetically Modified Rice Litig., 764 F.3d 864, 869 (8th Cir.
2014).
34. Id. Additionally, some types of work are often given more value than others,
e.g., taking depositions versus reviewing documents. Eldon E. Fallon, Common Benefit Fees in Multidistrict Litigation, 74 LA. L. REV. 371, 389 (2014).
35. See generally In re Latex Gloves Prods. Liab. Litig., MDL No. 1148, 2003
U.S. Dist. LEXIS 18118 (E.D. Pa. Sept. 5, 2003).
36. See, e.g., id.
37. See Genetically Modified Rice, 2010 WL 716190, at *2 (“Many plaintiffs’
lawyers represent plaintiffs in the federal cases as well as plaintiffs in the state cases.
In fact, all of the producer plaintiffs’ attorneys who object to this motion represent
plaintiffs in cases before me and in cases pending in state courts.”).
38. Id.
39. See id.
40. Id.
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quire the defendant to hold back a percentage of the state court recovery from
attorneys representing clients in both the federal MDL and state court?

A. The Federal MDL Court’s Jurisdiction Restrictions
There is a split of authority regarding the jurisdiction issue. Federal
courts are hesitant to assert jurisdiction over matters brought in state court,
but in cases in which there is a federal MDL and accompanying state court
litigation sharing the same core controversy, the jurisdictional limitations of
each court become unclear.41 With a lack of case law on this particular issue,
some courts have taken into account the issues raised in In re Showa Denko.42
In Showa Denko, the U.S. Court of Appeals for the Fourth Circuit reviewed
an MDL district court’s order of a holdback assessment that applied not only
to the cases transferred to the MDL court, but also to the related state court
cases and non-transferred federal cases.43 The court held that the MDL trial
court did not have jurisdiction to order a contribution from parties who appeared before different courts and not also before that MDL trial court.44
Further, the court concluded the authority to consolidate cases before one
MDL judge “is merely procedural and does not expand the jurisdiction of the
district court to which the cases are transferred.”45 Other courts have also
accepted this notion.46
However, the situation changes when the attorneys are before both state
and federal courts on behalf of multiple clients in the same dispute. As mentioned earlier, any attorney involved in the federal MDL will have access to
the work product obtained by the leadership group, regardless of whether he
or she is representing a client in the same dispute in state courts.47 The U.S.
District Court for the Eastern District of Pennsylvania analyzed both the ramifications of this work product accessibility and the contributions to the CBF
in In re Latex Gloves Products Liability Litigation.48 This court rejected the
application of Showa Denko, concluding, “[I]t is unnecessary to theorize that
every claimant benefits from the discovery completed by the plaintiffs’ steering committee, regardless [of] whether the case is in federal or state court,
41. In re Showa Denko K.K. L-Tryptophan Prods. Liab. Litig.-II, 953 F.2d 162,
165 (4th Cir. 1992).
42. Id. See In re Genetically Modified Rice Litig., 764 F.3d 864, 873–74 (8th
Cir. 2014); In re Syngenta AG MIR 162 Corn Litig., MDL No. 2591, 2015 WL
2165341, at *2–3 (D. Kan. May 8, 2015); In re Baycol Prods., No. MDL
1431MJD/JGL, 2004 WL 1058105, at *2 (D. Minn. May 3, 2004).
43. Showa Denko, 953 F.2d at 165.
44. Id.
45. Id.
46. See cases cited supra note 42. Contra In re Latex Gloves Prods. Liab. Litig.,
MDL No. 1148, 2003 U.S. Dist. LEXIS 18118, at *4–5 (E.D. Pa. Sept. 5, 2003).
47. See In re Genetically Modified Rice Litig., No. 4:06 MD 1811 CDP, 2010
WL 716190 (E.D. Mo. Feb. 24, 2010), aff’d, 764 F.3d 864 (8th Cir. 2014).
48. See Latex Gloves Prods., 2003 U.S. Dist. LEXIS 18118, at *2, *5.
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and whether suit has been instituted.”49 The court further reasoned, “Permitting [the plaintiffs’ counsel] to use discovery information in their state cases
without charge would produce an anomalous and undesirable predicament.”50
The U.S. Court of Appeals for the Eighth Circuit has also discussed the
problems stemming from this situation.51 In Walitalo v. Iacocca, the court
stated: “It is well established that courts can impose liability for courtappointed counsel’s fees on all plaintiffs benefitting from their services.”52 In
this case, attorneys attempted to avoid contributing their share to the CBF by
dismissing their cases from the MDL proceeding at the last minute before
settlement.53 When the lead counsel in federal court presented this dismissal
as an argument against allowing such conduct, the court found the argument
to be “completely without merit.”54 It found that if a court were to allow a
dismissal in this context, “[the court’s] power to appoint attorneys to act on
behalf of other attorneys and parties in complex litigation would be meaningless.”55 This is because, in a situation where attorneys are allowed to drop
from MDL litigation before settlement, they would still have access to the
federal MDL work product.56 Therefore, the plaintiffs’ steering committee
would have no incentive to produce the work product, knowing they would
not be justly compensated.57
Similar to the court in In re Latex Gloves Products Liability Litigation,
the court in Walitalo also identified an instance where attorneys attempted to
maneuver around their obligations to contribute to the CBF – in this case, by
withdrawing their clients from the MDL after receiving the benefit of work
product conducted by the leadership group.58 The court therefore required the
plaintiffs’ attorneys, who benefited from the work product obtained for the
purposes of the MDL, to contribute to the CBF.59
Conversely, some MDL courts have found a lack of jurisdiction to enforce the assessments for CBF purposes in related state court recoveries involving the same attorneys.60 In In re Genetically Modified Rice, a case
49.
50.
51.
52.

Id. at *4–5.
Id. at *5.
See, e.g., Walitalo v. Iacocca, 968 F.2d 741 (8th Cir. 1992).
Id. at 747; see also FED. JUDICIAL CTR., MANUAL FOR COMPLEX LITIGATION
29 (3d ed. 1995), http://www.classactionlitigation.com/library/mcl.pdf (“Whether or
not agreement is reached, the judge has the authority to order reimbursement and
compensation and the obligation to ensure that the amounts are reasonable.”).
53. See Walitalo, 968 F.2d at 745.
54. Id. at 750 n.11.
55. Id.
56. Id. at 749.
57. Id. at 747.
58. Id. at 745.
59. Id. at 749.
60. See In re Genetically Modified Rice Litig., No. 4:06 MD 1811 CDP, 2010
WL 716190, at *4 (E.D. Mo. Feb. 24, 2010), aff’d, 764 F.3d 864 (8th Cir. 2014); see
also Hartland v. Alaska Airlines, 544 F.2d 992, 1001 (9th Cir. 1976).
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heard by the U.S. District Court for the Eastern District of Missouri involving
many plaintiffs and attorneys from Missouri, the court offered a particularly
important remark regarding its jurisdiction over state court cases:
Plaintiffs’ leadership group asks me to include the state court cases in
this order, so that defendants would be required to hold back and contribute a portion of any settlements or judgments from those cases as
well as from the MDL cases. . . . I do not have jurisdiction to do this. .
. . I reach this conclusion reluctantly. Requiring all the lawyers who
have benefitted from the work of the leadership team to contribute to
their fees would be in the interests of justice, but it is beyond my jurisdiction to order.61

This court further recognized the injustice in its holding by mentioning
that attorneys who use the work product obtained from the MDL in their state
court case will be unjustly enriched.62 However, it felt that there was no way
to remedy the problem without exceeding its jurisdiction.63 This court placed
the onus on the state court to rectify the issue.64
The most recent opinion on this issue came from the U.S. District Court
for the District of Kansas in In re Syngenta AG MIR 162 Corn Litigation and
also involved attorneys and plaintiffs in the state of Missouri.65 Here, the
court similarly ruled that it did not have jurisdiction to impose assessments on
state court plaintiffs.66 It reasoned that if it were to exercise jurisdiction over
the defendant regarding the state court recoveries, there would be a possibility
that it would affect parties outside of the MDL (i.e., the state court plaintiffs).67 In support of its position, the court offered a hypothetical where the
CBF assessment in the MDL exceeded the total amount of state court attorneys’ fees.68 In that instance, “the Court would effectively be exerting its
authority over parties in cases not before it,” because the state court plaintiffs’
recovery amounts would be affected.69 For this reason, the court held that it
did not have the authority to order the defendant to hold back the CBF percentage on related state court cases.70 As mentioned above, this provides no
remedy or prevention method for the federal plaintiffs’ attorneys regarding

61.
62.
63.
64.
65.

Genetically Modified Rice, 2010 WL 716190, at *4–5.
Id. at *5.
Id.
Id.
In re Syngenta AG MIR 162 Corn Litig., MDL No. 2591, 2015 WL
2165341, at *1 (D. Kan. May 8, 2015).
66. Id. at *2–3.
67. Id.
68. Id.
69. Id. at *3.
70. Id. at *4.
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the improper use of federal work product in state court.71 The court found
that attorneys who use this work product in state court are unjustly enriched.72
Fearful of unjust enrichment litigation after the MDL, the attorneys involved in the federal MDL, In re Syngenta, who have several state court
plaintiffs, took steps to solve the problem from the outset.73 They did so by
making “efforts to promote appropriate federal-state cooperation and coordination.”74 Additionally, to avoid varying contributions to the CBF of the
state court and the CBF of the federal MDL, the state court matched the assessment percentage of the federal MDL.75 Furthermore, for plaintiffs’ attorneys in both state and federal court, an identical percentage was set aside to
help prevent duplicate assessment in both state and federal court.76 This,
however, did not prevent attorneys with cases involving the same core dispute in both the state court and the federal MDL from using the work product
produced for the federal MDL in their concurrent state court cases without
having to contribute any portion of the state court recoveries to the CBF established for the federal MDL.77 Thus, this result did not prevent the unjust
enrichment at the expense of attorneys only involved in the federal MDL.

B. Circuits Finding Jurisdiction over the MDL Defendant to Order
Holdbacks of State Court Recoveries
Other circuits have been more aggressive in preventing the unjust enrichment problem involving plaintiffs’ attorneys not having to contribute to
the federal CBF for their related state court cases. These courts cite “equity”
and “fairness” as appropriate justifications for stretching their jurisdiction in
these types of situations.78 In circumstances such as these, “allowances” can
be made “for dominating reasons of justice.”79 This idea was introduced by
the Supreme Court of the United States in Sprague v. Ticonic National Bank.
Since then, many courts have echoed this belief, especially regarding recent
CBF assessments.80
71. See generally In re Genetically Modified Rice Litig., No. 4:06 MD 1811
CDP, 2010 WL 716190, at *1 (E.D. Mo. Feb. 24, 2010), aff’d, 764 F.3d 864 (8th Cir.
2014).
72. Id.
73. In re Syngenta AG MIR 162 Corn Litig., MDL No. 2591, slip op. at 5–6 (D.
Kan. Jan. 22, 2015).
74. Id. at 5.
75. Id. at 5–6.
76. Id. at 6.
77. Id.
78. Sprague v. Ticonic Nat’l Bank, 307 U.S. 161, 167 (1939).
79. Id.
80. See generally In re Oil Spill by the Oil Rig “Deepwater Horizon” in the Gulf
of Mex., on Apr. 20, 2010, MDL No. 10-2771, 2011 WL 6817982, at *5 (E.D. La.
Dec. 28, 2011) (quoting Case Management Order No. 17 at ¶ 3(f)(3), In re Fosamax
Prods. Liab. Litig., No. 1:06-md-1786 (S.D.N.Y. Apr. 28, 2011)), order amended and
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Specifically, the court in Oil Spill referenced the above-cited cases on
both sides in its analysis – Genetically Modified Rice (for a lack of jurisdiction) and Latex Gloves (for jurisdiction).81 The Oil Spill court first noted that
Genetically Modified Rice stated “that requiring all lawyers – including those
with cases in state courts – who benefit from the work of appointed counsel
to contribute to a common benefit fund avoids unjust enrichment and therefore is in the interest of justice.”82 The court in Oil Spill went on to mention
that perceived jurisdictional restrictions were the only issues preventing the
Genetically Modified Rice court from ordering the defendant to hold back the
CBF percentage on related state court recoveries.83
The Oil Spill court contrasted Genetically Modified Rice with the holding in Latex Gloves, where the court found that no such jurisdictional restrictions existed.84 Ultimately, after analyzing and weighing the arguments
on both sides, the Oil Spill court found that, in the interest of justice, it should
order the holdback on related state court recoveries.85 It applied the CBF
holdback “to all actions filed in or removed to federal court that have been or
become a part of the MDL . . . or state court plaintiffs represented by counsel
who have participated in or had access to the discovery conducted in this
MDL.”86
The Oil Spill holding was a product of several other cases before it, including Fosamax Products Liability Litigation and Latex Gloves.87 In Fosamax, the opinion states that “any plaintiff’s counsel with cases not in the
MDL who utilizes any aspect of the MDL common benefit work product . . .
shall be subject to [a holdback assessment].”88 Therefore, the Fosamax court
also had no problem exercising its jurisdiction.89 In Latex Gloves, the court
recognized the equitable compulsion to assert its jurisdiction.90 It upheld an
agreement made between all of the plaintiffs’ attorneys in the MDL.91 The
superseded on reconsideration, 2012 WL 161194 (E.D. La. Jan. 18, 2012); In re
Latex Gloves Prods. Liab. Litig., MDL No. 1148, 2003 U.S. Dist. LEXIS 18118, at
*1–2 (E.D. Pa. Sept. 5, 2003); Walitalo v. Iacocca, 968 F.2d 741, 748 (8th Cir. 1992).
81. Oil Rig Deepwater Horizon, 2011 WL 6817982, at *5.
82. Id.
83. Id.
84. Id.
85. Id. at *6.
86. Id. (emphasis added).
87. Id. at *5 (quoting Case Management Order No. 17 at ¶ 3(f)(3), In re Fosamax
Prods. Liab. Litig., No. 1:06-md-1786 (S.D.N.Y. Apr. 28, 2011)); In re Latex Gloves
Prods. Liab. Litig., MDL No. 1148, 2003 U.S. Dist. LEXIS 18118, at *5 (E.D. Pa.
Sept. 5, 2003).
88. Oil Rig Deepwater Horizon, 2011 WL 6817982, at *5 (quoting Case Management Order No. 17 at ¶ 3(f)(3), In re Fosamax Prods. Liab. Litig., No. 1:06-md1786 (S.D.N.Y. Apr. 28, 2011)).
89. Id.
90. Latex Gloves Prods., 2003 U.S. Dist. LEXIS 18118, at *5.
91. Id.
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agreement was created “to obtain equitable sharing of litigation expenses
incurred and compensation for professional services provided by the [plaintiffs’ leadership committee].”92 It applied “to all actions in which plaintiffs
may enjoy the common benefit work product made available in this multidistrict litigation.”93 This would include those actions in related state court
cases in which the work product of the federal MDL can be applied.

C. A Recent Key Jurisdictional Case
The notion of equitable sharing of litigation expenses was affirmed in In
re Avandia Marketing, Sales Practices & Products Liability Litigation.94
This case was filed in federal court when a law firm refused to contribute a
stipulated seven percent of the total recovery to the CBF of the MDL proceeding.95 The firm only had twenty-five clients in federal court and thousands in state court, yet it had access to the entire work product collected by
the MDL plaintiffs’ steering committee.96 The firm then used that work
product in its California state court cases.97 Before the case was appealed to
the U.S. Court of Appeals for the Third Circuit, the U.S. District Court for the
Eastern District of Pennsylvania held that all settled claims, in both MDL and
California state court, were subject to the seven percent assessment, and it
ordered defendant to hold back that amount for the CBF.98 The Third Circuit
affirmed this ruling, finding the district court did not exceed its jurisdiction.99
In reaching its decision, the court discussed much of the relevant case law,
including two important cases, discussed previously in this Note, which
found a lack of jurisdiction – Genetically Modified Rice and Showa Denko.100
The Third Circuit began by referencing Showa Denko, stating, “[A]n order requiring state-court plaintiffs to contribute a portion of any recovery in
their cases to pay for the MDL coordinating counsel exceed[s] the district
court’s jurisdiction because those plaintiffs have not voluntarily entered the
litigation before the district court nor have they been brought in by process.”101 It then mentioned Genetically Modified Rice, which reiterated that
federal courts are without “jurisdiction to order state-court plaintiffs to contribute to a common benefit fund for MDL coordinating counsel,” as a lack of

92. Id. at *3.
93. Id.
94. In re Avandia Mktg., Sales Practices & Prods. Liab. Litig., 617 F. App’x

136, 138 (3d Cir. 2015).
95. Id.
96. Id. at 139.
97. Id.
98. Id. at 138.
99. Id.
100. Id. at 141.
101. Id.
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authority over parties not involved in cases before it is not overcome by equity considerations.102
In response to these holdings finding a lack of jurisdiction, the Third
Circuit summarized its finding as follows:
We agree with [the law firm] that had the District Court simply ordered the firm, as total strangers to the litigation, to contribute to the
common benefit fund from the settlement of its clients’ state-court
cases, it would have exceeded its jurisdiction. However, that is not
what the District Court did here. The proper question we must ask is
did the District Court properly exercise jurisdiction to enforce the contract [the law firm] made with the [MDL] Plaintiffs’ Steering Committee. We conclude that it did.103

Thus, because the law firm received the benefits of the MDL work
product, and they were involved in the MDL, the federal court did not abuse
its discretion in ordering the defendant to hold back seven percent of the entire recovery – including the state court recovery.104 For purposes of fairness,
the court in In re Avandia held that the parties were permitted to “trade work
product for a share in the recovery in cases not before the MDL,” and the
district court will not exceed its jurisdiction in enforcing this agreement.105

D. Principles of Comity and Federalism
The court in Zyprexa avoided deciding the jurisdictional issue entirely
by citing the principles of comity, a federalism doctrine, as a reason not to
order the holdback.106 Judicial comity involves a “courtesy of the court that
respects [the] judicial decisions of another state.”107 Generally speaking,
courts defer to other courts in matters that they believe belong to those
courts.108
Specifically, the court in Zyprexa Products found that “[t]here [was] no
need . . . to reach the issue of whether a federal MDL court has the power to
compel attorneys who represent both state and federal plaintiffs to set aside a
102.
103.
104.
105.
106.

Id.
Id.
Id.
Id.
See In re Zyprexa Prods. Liab. Litig., 467 F. Supp. 2d 256, 268 (E.D.N.Y.

2006).
107. What
is
Judicial
Comity,
LAW
DICTIONARY,
http://thelawdictionary.org/judicial-comity/ (last visited June 27, 2016).
108. Definition
of
Comity,
MERRIAM-WEBSTER, http://www.merriamTelephone
Interwebster.com/dictionary/comity (last visited Aug. 30, 2016);
view with Gretchen Garrison, Attorney, Gray, Ritter & Graham, P.C. (Oct. 7, 2015).
Ms. Garrison has dealt with these issues firsthand and worked on cases cited in this
Note. Audio recording on file with the author.
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portion of their fee recoveries in state cases for use in a common benefit
fund.”109 In its reasoning, the court stated: “Principles of comity and respect
for the state courts’ supervision of their own dockets and the attorneys before
them lead to the conclusion that such compulsion would be inappropriate.”110
Instead of seeing free work product for attorneys with state court clients as a
problem, as courts previously have, this court believed the result to be “desirable.”111 It believed this allowance helped prevent “duplication and repetition” in discovery, meaning attorneys will not have to obtain the same work
product for both state and federal court.112 Upon consideration of the unjust
enrichment problem, the court in Zyprexa Products refused to take any remedial action – saying it was not its responsibility to address the problem.113

D. Summary of Modern Trends
A pattern has emerged from these situations. Courts have repeatedly
recognized the inherent problems in allowing every attorney involved in the
litigation access to the work product obtained by the leadership group – specifically, those with coexisting state court cases.114 It has been established
that an attorney’s use of work product that was obtained for the MDL in state
court constitutes an unjust enrichment.115 This makes a subsequent unjust
enrichment lawsuit likely, especially when the unjust enrichment amounts to
many millions of dollars. As discussed above, authority is split on whether or
not MDL courts have jurisdiction to order the defendants to hold back the
CBF assessment on attorneys in both state court and the federal MDL.116
One court has found an inability to make such an order, not based on jurisdiction but on the general concept of comity.117 The following Part discusses the
options that the MDL courts have in determining the assessments for different
parties, as well as possible ways the attorneys themselves can prevent this
problem.

109.
110.
111.
112.
113.

Zyprexa Prods., 467 F. Supp. 2d at 268.
Id.
Id.
Id. (citing MacAlister v. Guterma, 263 F.2d 65, 69 (2d Cir.1958)).
Id. at 268–69 (“The issue of assessing state cases with the costs of a discovery process that benefits all cases, state and federal, should, in the first instance, be
left to state court judges.”).
114. See, e.g., In re Syngenta AG MIR 162 Corn Litig., MDL No. 2591, 2015 WL
2165341, at *4–5 (D. Kan. May 8, 2015).
115. In re Genetically Modified Rice Litig., No. 4:06 MD 1811 CDP, 2010 WL
716190, at *1 (E.D. Mo. Feb. 24, 2010), aff’d, 764 F.3d 864 (8th Cir. 2014).
116. See generally In re Latex Gloves Prods. Liab. Litig., MDL No. 1148, 2003
U.S. Dist. LEXIS 18118 (E.D. Pa. Sept. 5, 2003); Walitalo v. Iacocca, 968 F.2d 741
(8th Cir. 1992).
117. Zyprexa Prods., 467 F. Supp. 2d at 267–68.

Published by University of Missouri School of Law Scholarship Repository, 2016

13

Missouri Law Review, Vol. 81, Iss. 3 [2016], Art. 9

844

MISSOURI LAW REVIEW

[Vol. 81

IV. DISCUSSION
As indicated in the previous Parts, there are a number of MDLs with accompanying state court litigation. As is the case in many situations where
there is a split of authority, the problem stems from a fundamental difference
of interpretation regarding the court’s scope of jurisdiction. The main argument against allowing a federal court to order CBF assessments on the plaintiffs’ attorneys present in the federal MDL with related state court recoveries
is that the federal court lacks the jurisdiction to issue an order that impacts
parties not before it.118 However, those who argued that a federal court has
the authority to hold back the amount of the federal CBF assessment claim
jurisdiction is not an issue, because the court has authority over the party that
creates and controls the fund, i.e., the defendant.119 As will be discussed below, courts denying jurisdiction have struggled to respond to this argument.
In all likelihood, there are underlying public policy considerations playing a role in the federal courts’ decisions. In particular, the concept of federalism, often not explicitly mentioned in court opinions, is an ever-present
factor of consideration. The concept of federalism has been promoted since
the early days of the U.S. legal system.120 Whenever there is an issue regarding matters of federal court versus matters of state court, the principles of
federalism should be considered.121 In applying the concept of federalism to
this case, courts have referenced the “policy of comity.”122 Comity protects
the individual acts of each court through mutual recognition of and acknowledgment by other courts.123 In essence, due to the principles of comity, federal courts will likely try to limit their involvement with the affairs of state
courts.
Thus, a number of reasons prevent courts from ordering holdbacks on
plaintiffs’ attorneys in state court cases, including lack of jurisdiction and
principles of comity. But when an attorney takes work product obtained
strictly for a federal MDL and uses it for his or her related state court cases, it
is quite clear that the attorney has been unjustly enriched.124 Currently, there
are few remedies for this problem aside from subsequent litigation, which is
highly inefficient. The following section analyzes these considerations and
discusses possible resolutions that can be reached from the outset of the litigation.
118. In re Showa Denko K.K. L-Tryptophan Prods. Liab. Litig.-II, 953 F.2d 162,
166 (4th Cir. 1992); Hartland v. Alaska Airlines, 544 F.2d 992, 1001 (9th Cir. 1976).
119. Genetically Modified Rice, 2010 WL 716190, at *5.
120. See, e.g., THE FEDERALIST NO. 46 (James Madison).
121. Id. (“The federal and State governments are in fact but different agents and
trustees of the people, constituted with different powers . . . .”).
122. Showa Denko, 953 F.2d at 166.
123. Comity
Definition,
LEGAL
INFO.
INST.,
https://www.law.cornell.edu/wex/comity (last visited June 26, 2016).
124. Genetically Modified Rice, 2010 WL 716190, at *3.
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A. Jurisdictional Issues
When determining whether a court can exercise its jurisdiction in a given situation, one of the main concerns is that the court must not exercise jurisdiction over parties that are not in the litigation.125 In Genetically Modified
Rice, the Eighth Circuit addressed this issue.126 The plaintiffs’ lead counsel
argued that the court had jurisdiction over the defendant in the federal MDL
and, therefore, had jurisdiction to order the defendant to hold back the percentage of the CBF for related state-court recoveries for those plaintiffs’ attorneys with clients in both the federal MDL and state court.127 The court
responded to this argument by stating: “But state-court cases, related or not,
are not before the district court.”128 It went on to say, “The state-court plaintiffs at issue neither agreed to be part of the federal MDL nor participated in
the MDL Settlement Agreement.”129 Additionally, the court found that
“[e]ven if the state plaintiffs’ attorneys participated in the MDL, the district
court overseeing the MDL does not have authority over separate disputes
between state-court plaintiffs and [the defendant].”130 This is a valid argument only if the state court plaintiffs will be affected by the holdback. If they
are not, then the only parties involved in the CBF assessment are the plaintiffs, plaintiffs’ attorneys, and the defendant in the federal MDL. The MDL
court clearly has jurisdiction over each of these parties.
On the other hand, if the plaintiffs in state court are affected by a holdback ordered by the federal MDL court, that court has exceeded it jurisdiction.131 Judge Lungstrum of the U.S. District Court for the District of Kansas
provided a hypothetical where the state court plaintiffs would be impacted
negatively as a result of the defendant withholding the percentage allocated to
the federal CBF for the related state court recoveries.132 He illustrated a situation where the assessment percentage “could exceed the attorney’s own
fees paid by his client [in state court] (for instance, because the attorney

125. Hartland v. Alaska Airlines, 544 F.2d 992, 1001 (9th Cir. 1976).
126. In re Genetically Modified Rice Litig., No. 12-4045, slip op. at 16–17 (8th

Cir. Aug. 22, 2014).
127. Id.
128. Id.
129. Id.
130. Id. (emphasis omitted).
131. In re Showa Denko K.K. L-Tryptophan Prods. Liab. Litig.-II, 953 F.2d 162,
165–66 (4th Cir. 1992).
132. In re Syngenta AG MIR 162 Corn Litig., MDL No. 2591, 2015 WL
2165341, at *3 (D. Kan. May 8, 2015) (“As [defendant] points out, the effect of a
holdback may be to interfere with a state-court plaintiff’s total recovery, which belongs to the plaintiff and not to its attorney. Moreover, the assessment only of the
attorney’s share, as [the attorney group representing state court plaintiffs] describes
the assessment, could exceed the attorney’s own fees paid by his client (for instance,
because the attorney agreed to a lower percentage fee or was paid by the hour).”)
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agreed to a lower percentage fee or was paid by the hour).”133 However, given the traditional percentages of the state court attorneys’ contingency fees,
and the much lower CBF assessment percentage, it would be highly unlikely
for this situation to arise.134 While the CBF assessment percentages range
from only nine percent to seventeen percent, the typical contingent fee percentage for plaintiffs’ attorneys ranges from thirty-three percent to forty percent.135 As such, while it is hypothetically possible for the attorney to negotiate a contingency fee lower than the federal CBF assessment, in reality, this
would not occur.136 Even if there also existed a state court CBF, the sum of
both the federal and state court CBF contribution percentages would not exceed the total contingent fee percentage in state court.137 Thus, if an MDL
court orders its defendant to hold back the amount of the CBF assessment
percentage for the related state court recoveries, it would not affect parties not
before the MDL court.138
As mentioned above, the Eighth Circuit and District of Kansas have declined to recognize jurisdiction in this matter.139 Both Syngenta and Genetically Modified Rice were massive MDLs involving many attorneys and
plaintiffs within the State of Missouri.140 The holdings in these cases have
directly impacted the CBF assessments in federal and state court cases around
133. Id.
134. Telephone Interview with Gretchen Garrison, supra note 108.
135. See David Goguen, Lawyers’ Fees in Your Personal Injury Case, ALLLAW,

http://www.alllaw.com/articles/nolo/personal-injury/lawyers-fees.html (last visited
June 27, 2015). Hourly rates will rarely apply in this type of plaintiff representation;
the majority of the time, plaintiffs’ attorneys are working on a contingency fee basis.
Id. See also In re Genetically Modified Rice Litig., No. 4:06 MD 1811 CDP, 2010
WL 716190, at *6 (E.D. Mo. Feb. 24, 2010) (“Courts have ordered contributions
between 9% and 17% in MDLs for common benefit work.”), aff’d, 764 F.3d 864 (8th
Cir. 2014).
136. Telephone Interview with Gretchen Garrison, supra note 108.
137. Id.
138. Typically, the CBF is divided into an “attorneys’ fees” portion and a “costs”
portion. Genetically Modified Rice, 2010 WL 716190, at *6. The costs portion is
typically allocated to the plaintiffs. Id. at *2. Therefore, a federal MDL courtordered assessment on related state court cases would theoretically affect the state
court plaintiffs not before the federal court, but the costs of litigation are discussed
and negotiated from the outset of the attorney’s representation in the litigation. Id.
The contractual relationship determines this extra expense, so although the court determines the additional assessment, this assessment is executed pursuant to a negotiated agreement between the plaintiffs and their attorneys. Id. As such, the cost portion
does not necessarily offer any additional unexpected burden to the plaintiffs. Id. at
*7. However, for the purposes of this analysis, only the attorneys’ fees portion of the
CBF is to be considered. It is this portion that undoubtedly will not affect parties not
before the federal MDL. Id. at *6.
139. Id. at *4; In re Syngenta AG MIR 162 Corn Litig., MDL No. 2591, 2015 WL
2165341, at *4 (D. Kan. May 8, 2015).
140. Genetically Modified Rice, 2010 WL 716190, at *1.
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the region and have made it possible for plaintiffs’ attorneys to use the federal
courts’ jurisdictional argument to their advantage.
Other courts across the country, however, have disregarded these perceived jurisdictional restrictions and ordered defendants to hold back the
amount of the federal MDL CBF contribution percentage from state court
recoveries for overriding purposes of equity.141 Indeed, few would argue that
it is fair to allow less involved attorneys access to work product, gathered
through conducting thousands of hours of work and hiring expensive experts,
without having to contribute any portion of their attorney’s fees to the attorneys who actually created the work product. While the federal MDL courts
have limited jurisdiction over such matters, several courts have been able to
find a solution to the unjust enrichment problem while operating within their
jurisdiction.142
In coming to this solution, federal MDL courts seeking to prevent unjust
enrichment have limited the scope of their jurisdiction regarding holdbacks to
orders that only affect parties before the MDL court.143 As the courts in
Avandia and Oil Spill determined, they can stay within their bounds and yet
still prevent the unjust enrichment.144 Specifically, the court in Avandia
acknowledged the main restriction outlined in Showa Denko and Genetically
Modified Rice – i.e., the MDL court will not be able to order contributions to
the CBF from parties not before it.145 The existence of this restriction is one
on which all federal MDL courts have agreed. The source of the disagreement has come when determining the perceived effects of an order given to
the defendant to hold back the federal MDL CBF percentage on all concurrent state court recoveries obtained after receiving the benefits of the work
product.146
As analyzed in Part III, the probability that a holdback order of a small
percentage of the overall state court recovery would affect a party not before

141. See generally In re Oil Spill by the Oil Rig “Deepwater Horizon” in the Gulf
of Mex., on Apr. 20, 2010, MDL No. 10-2771, 2011 WL 6817982 (E.D. La. Dec. 28,
2011) (quoting Case Management Order No. 17 at ¶ 3(f)(3), In re Fosamax Prods.
Liab. Litig., No. 1:06-md-1786 (S.D.N.Y. Apr. 28, 2011)), order amended and superseded on reconsideration, 2012 WL 161194 (E.D. La. Jan. 18, 2012); In re Latex
Gloves Prods. Liab. Litig., MDL No. 1148, 2003 U.S. Dist. LEXIS 18118 (E.D. Pa.
Sept. 5, 2003); Walitalo v. Iacocca, 968 F.2d 741 (8th Cir. 1992).
142. See generally Oil Rig Deepwater Horizon, 2011 WL 6817982, at *5 (quoting
Fosamax Prods., No. 1:06–md–1786); Latex Gloves Prods., 2003 U.S. Dist. LEXIS
18118.
143. See generally Oil Rig Deepwater Horizon, 2011 WL 6817982, at *5 (quoting
Fosamax Prods., No. 1:06–md–1786); Latex Gloves Prods., 2003 U.S. Dist. LEXIS
18118.
144. See generally Oil Rig Deepwater Horizon, 2011 WL 6817982; In re Avandia
Mktg., Sales Practices & Prods. Liab. Litig., 617 F. App’x 136 (3d Cir. 2015).
145. Avandia Mktg., 617 F. App’x at 141.
146. Id.
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the federal MDL court is insignificant.147 Even if the attorneys with concurrent individual state court cases formed an MDL and created a CBF of their
own in state court, the sum of the state court and federal contributions to their
respective CBFs would virtually never exceed the percentage of total attorney’s fees.148 An average contribution is between nine percent and eleven
percent and has been determined unreasonable if it exceeds seventeen percent.149 Given that the lower end of plaintiff’s attorney’s contingent fees in
state court is one third,150 even a larger contribution made twice, for the state
and federal MDL CBF, would not surpass the total contingent fee percentage.
Thus, a holdback order in the federal MDL would only affect the attorneys
before the federal MDL, not the state court plaintiffs or any other party.
Considering these limited effects, courts should freely issue such orders
in the interests of justice and equity. The cited jurisdictional restrictions do
not limit the courts’ ability in this situation. Therefore, this is ultimately an
issue that should be resolved by the federal MDL court through an order issued to the defendant to hold back the CBF percentage for all recoveries –
state and federal – obtained by attorneys who received the benefit of the work
product created for the purposes of the federal MDL.

C. Conclusion Regarding the Issue of Jurisdiction
In sum, several courts have been hesitant to exercise jurisdiction in these
matters. Courts around Missouri, involving Missouri lawyers and plaintiffs,
have found that they do not have jurisdiction to order the defendant to hold
back the CBF assessment amount.151 However, several courts around the
country have extended their jurisdiction, allowing them to make such an order.152 These courts have done so for purposes of fairness, in order to prevent
147. Telephone Interview with Gretchen Garrison, supra note 108.
148. See In re Genetically Modified Rice Litig., No. 4:06 MD 1811 CDP, 2010

WL 716190, at *6 (E.D. Mo. Feb. 24, 2010) (discussing reasonable CBF percentages), aff’d, 764 F.3d 864 (8th Cir. 2014).
149. Id.
150. Telephone Interview with Gretchen Garrison, supra note 108; Goguen, supra
note 135.
151. Genetically Modified Rice, 2010 WL 716190, at *1; see also Order Establishing Protocols for Common Benefit Work and Expenses and Establishing the
Common Benefit Fee and Expense Funds, In re Syngenta AG MIR 162 Corn Litig.,
MDL No. 2591, 2015 WL 2165341, at *3 (D. Kan. May 8, 2015).
152. Sprague v. Ticonic Nat’l Bank, 307 U.S. 161, 167 (1939). See In re Oil Spill
by the Oil Rig “Deepwater Horizon” in the Gulf of Mex., on Apr. 20, 2010, MDL No.
10-2771, 2011 WL 6817982, at *4, *6 (E.D. La. Dec. 28, 2011) (quoting Case Management Order No. 17 at ¶ 3(f)(3), In re Fosamax Prods. Liab. Litig., No. 1:06-md1786 (S.D.N.Y. Apr. 28, 2011)), order amended and superseded on reconsideration,
2012 WL 161194 (E.D. La. Jan. 18, 2012); see also In re Latex Gloves Prods. Liab.
Litig., MDL No. 1148, 2003 U.S. Dist. LEXIS 18118, at *5 (E.D. Pa. Sept. 5, 2003);
In re Avandia Mktg., Sales Practices & Prods. Liab. Litig., 617 F. App’x 136, 143–
44 (3d Cir. 2015).
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unjust enrichment.153 In these instances, a court is left in a difficult predicament: it can either make sure it does not stretch its jurisdictional restrictions
and ensure that it is operating within its boundaries, or it can risk exceeding
its jurisdiction for the overriding purpose of fairness. Courts that have done
the latter have done so understanding that, given the nature of the CBF assessment system, with the federal court defendant holding back the funds
from the attorneys in state court, the court’s order will not affect parties not
before it.154
These courts have resolved this issue without exceeding their perceived
jurisdiction. Furthermore, the plaintiffs’ attorneys will be free to apply the
work product conducted in furtherance of the federal MDL to their state court
cases after agreeing to contribute a portion of those recoveries to the federal
MDL CBF. Not only is this just, but it also produces an efficient result. Attorneys will no longer have an incentive to file as many suits as possible in
state court and as few as possible in the federal MDL. They will simply file
wherever they believe they can legitimately obtain the best result for their
clients. This is the ideal solution.

D. Issue of Comity Raised in Zyprexa
Not only did the court in Zyprexa Products refuse to take any action to
remedy the problem, it openly encouraged the attorneys to use the federal
work product to their advantage in state court.155 As mentioned by the court,
the free flow of work product between attorneys in different courts is efficient
and desirable,156 but it also causes serious problems if there is no way to adequately compensate the plaintiffs’ attorneys in the federal court who are actually creating the work product.157 Not only does it lead to an inequitable result, but it also creates a disincentive for the MDL plaintiffs’ lead counsel to
do the work necessary to adequately try a case – knowing they will not be
justly compensated.158
153. Sprague, 307 U.S. at 167; see also Genetically Modified Rice, 2010 WL
716190, at *1.
154. See Sprague, 307 U.S. at 167; Oil Rig Deepwater Horizon, 2011 WL
6817982, at *6 (quoting Fosamax Prods., No. 1:06–md–1786); Latex Gloves Prods.,
2003 U.S. Dist. LEXIS 18118, at *5.
155. In re Zyprexa Prods. Liab. Litig., 467 F. Supp. 2d 256, 268 (E.D.N.Y. 2006)
(“Those attorneys are free to use relevant knowledge gained in the federal litigation
for the benefit of their state clients. The court has consistently refused to erect any
artificial barrier, or ‘Chinese wall,’ between the federal and state cases that would
limit state attorneys’ ability to profit from federal discovery.”).
156. Id. at 268–69.
157. In re Genetically Modified Rice Litig., No. 4:06 MD 1811 CDP, 2010 WL
716190, at *1 (E.D. Mo. Feb. 24, 2010) (“The lawyers and plaintiffs who have not
agreed to join in the trust will have been unjustly enriched if they are not required to
contribute to the fees of the leadership lawyers.”), aff’d, 764 F.3d 864 (8th Cir. 2014).
158. Zyprexa Prods., 467 F. Supp. 2d at 268.

Published by University of Missouri School of Law Scholarship Repository, 2016

19

Missouri Law Review, Vol. 81, Iss. 3 [2016], Art. 9

850

MISSOURI LAW REVIEW

[Vol. 81

The Zyprexa Products court took an idealistic view of state courts’ and
attorneys’ abilities to resolve this issue. The only advice offered by the court
was a suggestion that “the parties voluntarily resolve the issue of payment for
[plaintiffs’ leadership group] work by agreeing that attorneys with state cases
will assume an equitable proportionate share of the costs of discovery in this
litigation.”159 This typically involves a contract between the attorneys in
which they all agree to contribute a percentage to the federal CBF for all recoveries – state and federal.160
In reality, however, these types of contracts are difficult to create and
enforce, because they are often contingent on court rulings regarding the allocation of the CBF.161 Furthermore, because of the advantages of being in
state court, attorneys are reluctant to make contractual agreements with the
plaintiffs’ leadership group in federal court.162 Attorneys recognize that they
will not be ordered to contribute to the CBF in the concurrent federal
MDL.163 For this reason, many attorneys simply do not want to contribute to
the federal MDL from their state court recoveries or negotiate any contractual
agreement, which would require them to contribute a portion of their state
court cases to the federal MDL.164 Accordingly, they are difficult to bargain
with when attempting to make a contractual agreement regarding the CBF
contributions.165 Even when threatened with unjust enrichment litigation at
the conclusion of the MDL,166 attorneys representing state court plaintiffs are
still reluctant to agree to any contract that would require them to contribute to
the federal CBF from their state court recoveries.167
Considering these factors, the court in Zyprexa Products overestimated
the plaintiffs’ attorneys’ ability to resolve the issue themselves.168 If the attorneys cannot voluntarily resolve the issue, and the federal MDL court refuses to act, then only one remedy remains for the plaintiffs’ leadership counsel – to sue for unjust enrichment.169

159.
160.
161.
162.
163.

Id. at 269.
Telephone Interview with Gretchen Garrison, supra note 108.
Id.
Id.
In re Genetically Modified Rice Litig., No. 4:06 MD 1811 CDP, 2010 WL
716190, at *1 (E.D. Mo. Feb. 24, 2010), aff’d, 764 F.3d 864 (8th Cir. 2014).
164. Telephone Interview with Gretchen Garrison, supra note 108.
165. Id.
166. Genetically Modified Rice, 2010 WL 716190, at *1.
167. Telephone Interview with Gretchen Garrison, supra note 108.
168. See In re Zyprexa Prods. Liab. Litig., 467 F. Supp. 2d 256, 269 (E.D.N.Y.
2006).
169. Telephone Interview with Gretchen Garrison, supra note 108; see Genetically Modified Rice, 2010 WL 716190, at *1.
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E. Subsequent Unjust Enrichment Litigation
Rather than coming to an equitable contractual agreement with the
plaintiffs’ leadership counsel for the federal MDL, many attorneys would
prefer to wait it out and possibly face subsequent unjust enrichment litigation.170 Not only is this strategy foolish, but it is also highly inefficient.171
Numerous courts have expressly stated that attorneys will be unjustly enriched if they use the work product of the federal MDL in related state court
cases without making any contribution to the federal CBF.172 Because of the
findings of these courts, unjust enrichment lawsuits are quite difficult to defend against.173
With a low probability of success in subsequent unjust enrichment litigation, it seems the attorneys who are unwilling to make a contractual agreement with the federal MDL plaintiffs’ lead counsel are banking on the fact
that, due to the expenses of litigation, the plaintiffs’ lead counsel will decide
not to pursue subsequent litigation against them.174 However, due to the scale
of these cases, the amount of money potentially owed to the federal CBF as a
result of the state court recoveries can be in the tens of millions of dollars.175
Moreover, unjust enrichment litigation such as this taxes the judicial resources of the courts and the attorneys involved.176 When attorneys have to
sue other attorneys for money, the focus is shifted away from their clients,
who they will have less time to help. Nevertheless, if the federal MDL court
declines to hear these cases on the basis of lack of jurisdiction or principles of
comity, subsequent litigation is the only legitimate remedy afforded to the
plaintiffs’ leadership counsel.177 This is the worst outcome for both the attorneys and the courts.
170. Telephone Interview with Gretchen Garrison, supra note 108.
171. Id.
172. Genetically Modified Rice, 2010 WL 716190, at *1. See also In re Oil Spill

by the Oil Rig “Deepwater Horizon” in the Gulf of Mex., on Apr. 20, 2010, MDL No.
10-2771, 2011 WL 6817982, at *5–6 (E.D. La. Dec. 28, 2011) (quoting Case Management Order No. 17 at ¶ 3(f)(3), In re Fosamax Prods. Liab. Litig., No. 1:06-md1786 (S.D.N.Y. Apr. 28, 2011)), order amended and superseded on reconsideration,
2012 WL 161194 (E.D. La. Jan. 18, 2012); In re Latex Gloves Prods. Liab. Litig.,
MDL No. 1148, 2003 U.S. Dist. LEXIS 18118, at *5 (E.D. Pa. Sept. 5, 2003).
173. Telephone Interview with Gretchen Garrison, supra note 108.
174. Id.
175. See, e.g., Order Adopting the Report and Recommendations of the Special
Master for the Allocation and Distribution of Common Benefit Fees and Expenses at
3–4, In re Genetically Modified Rice Litig., No. 4:06MD1811 CDP (E.D. Mo. Dec. 6,
2012). In this case, there were 918 million dollars in total recovery, and only 577
million was recovered in federal court. See id. The other 341 million was recovered
in state court. See id. The state court plaintiffs’ attorneys refused to pay the federal
MDL’s CBF assessment of 7.8 percent on those recoveries. See id. Therefore, roughly 26.6 million dollars were left out of the federal CBF. See id.
176. Telephone Interview with Gretchen Garrison, supra note 108.
177. Id.
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V. CONCLUSION
The use of work product conducted for federal MDLs in related state
court cases, with no contribution to the federal CBF, is an issue that will continue to present itself in courts across the country. Due to jurisdictional restraints, some courts have declined to take action that would impact the state
court attorneys’ fees. These courts have expressly stated they cannot make an
order that would impact parties not before the court. However, as shown in
Part III, it is unlikely that ordering a defendant in federal court to hold back
the amount of the CBF assessment percentage from related state court recoveries will impact parties not before the MDL court. Conversely, other courts
have made such orders due to overriding purposes of equity and fairness.
This is the most efficient and ideal resolution of the problem. It requires no
additional litigation and allows for the most efficient exchange of discovery
information.
Before addressing issues of jurisdiction, one court held that issues of
federalism, specifically the principles of comity, must first be addressed.178
Here, the court refused179 to involve itself in matters of the state court out of
respect for those courts and the judicial system as a whole.180 It placed the
onus on the attorneys to come to a resolution on their own. If they are unable
to reach an agreement, a subsequent unjust enrichment lawsuit is likely to
take place. This result places a burden on judicial resources and the attorneys.
Ultimately, it is the duty of the courts to ensure the proceedings are equitable and fair to all parties, attorneys included. MDL courts have the ability
to operate within their jurisdiction by ordering their defendants to incorporate
the state court recoveries in its CBF holdbacks. Doing so serves the highest
purpose of the judicial system.

178. See id.
179. Id.
180. Id.
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